These findings would extend and deepen our understanding of the role of FCN3 and SBDS in HCC, and it is suggested the regulation of the FCN3/YBX1/SBDS axis may be a novel strategy for the treatment of HCC. This evidence concerns the gene FCN3 and hepatocellular carcinoma.